Range
52.01 - 53.41
Vol / Avg.
211.5K/1.4M
Div / Yield
-
52 Wk
43 - 151.8
Mkt Cap
9.9B
Payout Ratio
-
Open
52.13
P/E
-
EPS
-0.32
Shares
186.2M
Outstanding
186.2M
Total Float
75.6M
Benzinga - Jun 23, 2021, 1:34PM
Benzinga - Jun 18, 2021, 11:42AM
load more
CureVac NV a clinical-stage biopharmaceutical company, developing a new class of transformative medicines based on messenger ribonucleic acid that has the potential to improve the lives of people. The company's product portfolio includes clinical and pre-clinical candidates across multiple disease indications in oncology, prophylactic vaccines and protein therapy. Its clinical programs are CV8102, which it is evaluating in Phase 1 clinical trial for the treatment of four types of solid tumors, and CV7202, which it is investigating in Phase 1 clinical trial for potential vaccination against rabies. It is also rapidly advancing its mRNA vaccine program against coronavirus SARS- CoV-2, for which the company initiated a Phase 1 clinical trial.

Related Companies

TickerCompanyChg %Mkt Cap
CVACCureVac1.49%9.9B

CureVac Frequently Asked Questions

Q

How do I buy CureVac (CVAC) stock?

A

You can purchase shares of CureVac (NASDAQ: CVAC) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are CureVac's (CVAC) competitors?

A

There are no as such competitors for CureVac.

Q

What is the target price for CureVac (CVAC) stock?

A

There is no analysis for CureVac

Q

Current Stock Price for CureVac (CVAC)?

A

The stock price for CureVac (NASDAQ: CVAC) is $53.15 last updated Today at 6:54:34 PM.

Q

Does CureVac (CVAC) pay a dividend?

A

There are no upcoming dividends for CureVac.

Q

When is CureVac (NASDAQ:CVAC) reporting earnings?

A

CureVac does not have any upcoming earnings scheduled.

Q

Is CureVac (CVAC) going to split?

A

There is no upcoming split for CureVac.

Q

What sector and industry does CureVac (CVAC) operate in?

A

CureVac is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.